PSMA overexpression in prostate cancer cells, which are particularly sensitive to folate-depleted conditions, enhances their survival in folate-depleted conditions by increasing the uptake of folic acid and converting polyglutamated folates into more easily absorbed monoglutamated forms [49,50,51]. Here, FOLH1 is linked to prostate carcinoma.